Will Rigetti Computing Make a Comeback in 2026?

Rigetti Computing (RGTI), a roughly $7 billion market-cap quantum start-up, has seen volatile 2025 performance—up about 50% year-to-date but roughly 60% off its October peak—after failing to advance to DARPA’s stage B quantum hardware contract, a setback that contrasts with peers such as IonQ and IBM that did advance. The company lacks a legacy cash-generating business and depends on winning research and defense contracts or outside funding, leaving its near-term recovery tied to broader risk appetite and material contract wins; the piece concludes the sector remains high-risk/high-reward with several nonlegacy players likely to fail.

Analysis

Market structure: DARPA’s Stage-B exclusion of RGTI is a binary signal that institutional demand (govt + defense) is concentrating on a handful of vendors (IONQ, IBM) and legacy tech (MSFT/GOOGL) that can absorb long development timelines. Small-cap hardware specialists (RGTI, other upstarts) are now price-sensitive: RGTI’s ~$7bn market cap and ~60% off Oct highs but +50% YTD implies speculative flows dominate, not fundamentals. Increased selectivity will compress pricing power for losers and raise valuation dispersion across the cohort.

Risk assessment: Tail risks include a cash-runway-triggered dilutive equity raise or bankruptcy within 6–12 months if contracts don’t materialize; operational tail risks include failed scale of error-correction (>18–36 months). Near-term (days–weeks) expect event-driven IV spikes around DARPA/contract news; medium-term (3–12 months) is funding-driven consolidation; long-term (1–3+ years) is technology consolidation and winner-take-most dynamics.

Trade implications: Prefer relative-value exposure to validated players (long IONQ, IBM) and defensive large caps (MSFT/GOOGL/NVDA) while keeping small, asymmetric exposure to RGTI. Use small short/hedge positions on RGTI to monetize funding risk and buy cheap long-dated options for binary upside; avoid outright large-cap heroics in the small-cap quantum names without contract proof points.

Contrarian angles: The market equates DARPA exclusion with permanent failure — that’s likely overdone; RGTI could be an acquisition target or pivot to cloud/software within 12–24 months, creating binary upside. Conversely, consensus underestimates dilution risk: if RGTI raises capital at >20% discount, equity value could fall materially; monitor cash runway and contract milestones as primary mispricing drivers.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in IONQ (IONQ) over the next 2–4 weeks; target 12-month hold, take profits at +50%, and hard stop at -30% to capture premium for DARPA-validated vendors.
• Initiate a 1–1.5% portfolio synthetic short on RGTI for 3–6 months (borrowed shares or pair with calls) to capitalize on funding/contract risk; cover if RGTI announces a Stage-B contract win or if its share price rallies >40% in any 30-day window.
• Allocate 0.5% capital to RGTI 12-month LEAP calls (150% OTM) as a capped asymmetric upside bet; simultaneously buy 3–6 month puts on RGTI sized to net ~0.5% downside protection against a dilution event.
• Increase combined exposure to MSFT/GOOGL/NVDA by 2–4% (equal-weight) via cash buys or 9–12 month call options to gain durable quantum optionality with defensive cash flow; trim if the S&P 500’s risk-off selloff widens credit spreads by >150bp.
• Set hard monitoring triggers: if RGTI reports cash runway <12 months, or announces an equity raise with >15% dilution, reduce long exposure by 50% and increase short hedges; if RGTI wins a $50M+ contract or Stage-B DARPA status, re-evaluate cover strategy within 48 hours.